These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37158850)

  • 1. TRIM37 exacerbates hepatic ischemia/reperfusion injury by facilitating IKKγ translocation.
    Yang H; Huang Z; Luo Y; Lei D; Yan P; Shen A; Liu W; Li D; Wu Z
    Mol Med; 2023 May; 29(1):62. PubMed ID: 37158850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM37 negatively regulates inflammatory responses induced by virus infection via controlling TRAF6 ubiquitination.
    Zhao L; Hao Y; Song Z; Fan Y; Li S
    Biochem Biophys Res Commun; 2021 Jun; 556():87-92. PubMed ID: 33839419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ATM/TRIM37/NEMO Axis Counteracts Genotoxicity by Activating Nuclear-to-Cytoplasmic NF-κB Signaling.
    Wu G; Song L; Zhu J; Hu Y; Cao L; Tan Z; Zhang S; Li Z; Li J
    Cancer Res; 2018 Nov; 78(22):6399-6412. PubMed ID: 30254148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DUSP9 alleviates hepatic ischemia/reperfusion injury by restraining both mitogen-activated protein kinase and IKK in an apoptosis signal-regulating kinase 1-dependent manner.
    Li Z; Huang Z; Luo Y; Yang H; Yang M
    Acta Biochim Biophys Sin (Shanghai); 2022 Dec; 54(12):1811-1821. PubMed ID: 36789693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM37 Augments AP-2γ Transcriptional Activity and Cellular Localization via K63-linked Ubiquitination to Drive Breast Cancer Progression.
    Cui G; Gao Z; Chang S; Narwade N; Chen Y; Poudel B; Lei KMK; Zhang W; Li G; Poon TCW; Cheung E
    Int J Biol Sci; 2022; 18(11):4316-4328. PubMed ID: 35864973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin inhibits the proliferation and invasion of ovarian cancer cells by suppressing tripartite motif-containing 37-induced tumor necrosis factor receptor-associated factor 2 ubiquitination.
    Zheng Y; Zhang H; Sun H
    Cancer Sci; 2022 Nov; 113(11):3776-3786. PubMed ID: 35950370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM37 controls cancer-specific vulnerability to PLK4 inhibition.
    Meitinger F; Ohta M; Lee KY; Watanabe S; Davis RL; Anzola JV; Kabeche R; Jenkins DA; Shiau AK; Desai A; Oegema K
    Nature; 2020 Sep; 585(7825):440-446. PubMed ID: 32908304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-942-5p prevents sepsis-induced acute lung injury via targeting TRIM37.
    Lu Q; Zhang D; Liu H; Xu H
    Int J Exp Pathol; 2021 Aug; 102(4-5):192-199. PubMed ID: 34716956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NF-κB activation.
    Hinz M; Stilmann M; Arslan SÇ; Khanna KK; Dittmar G; Scheidereit C
    Mol Cell; 2010 Oct; 40(1):63-74. PubMed ID: 20932475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASB16-AS1 up-regulated and phosphorylated TRIM37 to activate NF-κB pathway and promote proliferation, stemness, and cisplatin resistance of gastric cancer.
    Fu T; Ji K; Jin L; Zhang J; Wu X; Ji X; Fan B; Jia Z; Wang A; Liu J; Bu Z; Ji J
    Gastric Cancer; 2021 Jan; 24(1):45-59. PubMed ID: 32572790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FBXW5 aggravates hepatic ischemia/reperfusion injury via promoting phosphorylation of ASK1 in a TRAF6-dependent manner.
    Li TT; Luo YH; Yang H; Chai H; Lei ZL; Peng DD; Wu ZJ; Huang ZT
    Int Immunopharmacol; 2021 Oct; 99():107928. PubMed ID: 34217994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of I(kappa)B kinase complex by phosphorylation of (gamma)-binding domain of I(kappa)B kinase (beta) by Polo-like kinase 1.
    Higashimoto T; Chan N; Lee YK; Zandi E
    J Biol Chem; 2008 Dec; 283(51):35354-67. PubMed ID: 18957422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-194 ameliorates hepatic ischemia/reperfusion injury via targeting PHLDA1 in a TRAF6-dependent manner.
    Luo YH; Huang ZT; Zong KZ; Cao ZR; Peng DD; Zhou BY; Shen A; Yan P; Wu ZJ
    Int Immunopharmacol; 2021 Jul; 96():107604. PubMed ID: 33839577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tripartite motif-containing 37 (TRIM37) promotes the aggressiveness of non-small-cell lung cancer cells by activating the NF-κB pathway.
    Li Y; Deng L; Zhao X; Li B; Ren D; Yu L; Pan H; Gong Q; Song L; Zhou X; Dai T
    J Pathol; 2018 Nov; 246(3):366-378. PubMed ID: 30043491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM37 promotes the aggressiveness of ovarian cancer cells and increases c-Myc expression by binding to HUWE1.
    Li D; Zhang Z
    Arch Biochem Biophys; 2022 Oct; 728():109372. PubMed ID: 35921902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM37 overexpression is associated with chemoresistance in hepatocellular carcinoma via activating the AKT signaling pathway.
    Tan G; Xie B; Yu N; Huang J; Zhang B; Lin F; Li H
    Int J Clin Oncol; 2021 Mar; 26(3):532-542. PubMed ID: 33387087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIM37: a critical orchestrator of centrosome function.
    Domínguez-Calvo A; Gönczy P; Holland AJ; Balestra FR
    Cell Cycle; 2021 Dec; 20(23):2443-2451. PubMed ID: 34672905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ROS/NF-κB Signaling Pathway-Mediated Transcriptional Activation of TRIM37 Promotes HBV-Associated Hepatic Fibrosis.
    Xie H; Xie D; Zhang J; Jin W; Li Y; Yao J; Pan Z; Xie D
    Mol Ther Nucleic Acids; 2020 Aug; 22():114-123. PubMed ID: 32916597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of hepatitis B virus surface protein in inducing Sertoli cell ferroptosis.
    Pan C; Kong X; Wu Z; Fei Q
    Andrology; 2024 Mar; 12(3):643-654. PubMed ID: 37644905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tripartite Motif-Containing 27 Attenuates Liver Ischemia/Reperfusion Injury by Suppressing Transforming Growth Factor β-Activated Kinase 1 (TAK1) by TAK1 Binding Protein 2/3 Degradation.
    Chen SY; Zhang HP; Li J; Shi JH; Tang HW; Zhang Y; Zhang JK; Wen PH; Wang ZH; Shi XY; He YT; Hu BW; Yang H; Guo WZ; Zhang SJ
    Hepatology; 2021 Feb; 73(2):738-758. PubMed ID: 32343849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.